Sutro Biopharma STRO
NASDAQ STRO
$16.27 +0.17 (+1.06%)
As of: Sep 30, 2026 · 3:24 PM EDT

Sutro Biopharma (STRO) Liabilities and Shareholders Equity (2017 - 2026)

Updated

Sutro Biopharma (STRO) recorded Liabilities and Shareholders Equity of $194.46 million in Q2 2026, down 25.9% from $262.36 million a year earlier.

Analysis

Sutro Biopharma (STRO) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

At the end of FY2025, Sutro Biopharma reported Liabilities and Shareholders Equity of $173.83 million, down 55.1% from FY2024.

  • Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of -15.1% (FY2020 to FY2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $387.21 million in FY2024 (-17.7%), $470.74 million in FY2023 (+15.7%), $406.94 million in FY2022 (+19.2%) and $341.41 million in FY2021 (-13.4%).
  • Quarterly Liabilities and Shareholders Equity has ranged from $173.83 million in Q4 2025 to $489.04 million in Q2 2024 over the past five years.
  • On a year-over-year basis, Liabilities and Shareholders Equity rose in 1 of the last seven quarters, with an average decline of 30.6%.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 20.9% in Q3 2021, against a decline of 55.1% in Q4 2025 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 201.06 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 135.12 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 115.83 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 27.42 Bn
10 Sutro Biopharma 266.88 Mn -411.62 Mn - 194.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 194.46 Mn
Dec 31, 2025 173.83 Mn
Sep 30, 2025 209.66 Mn
Jun 30, 2025 262.36 Mn
Mar 31, 2025 321.43 Mn
Dec 31, 2024 387.21 Mn
Sep 30, 2024 451.83 Mn
Jun 30, 2024 489.04 Mn
Mar 31, 2024 403.40 Mn
Dec 31, 2023 470.74 Mn
Sep 30, 2023 431.73 Mn
Jun 30, 2023 464.90 Mn
Mar 31, 2023 358.02 Mn
Dec 31, 2022 406.94 Mn
Sep 30, 2022 400.70 Mn
Jun 30, 2022 385.62 Mn
Mar 31, 2022 303.68 Mn
Dec 31, 2021 341.41 Mn
Sep 30, 2021 371.47 Mn
Jun 30, 2021 359.79 Mn
API Access

Sutro Biopharma Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=STRO&period=max&api_key=YOUR_API_KEY